Ropes & Gray Represents Avista Capital Partners in Agreement to Invest in eMolecules
Ropes & Gray represented Avista Capital Partners in agreement to invest in eMolecules, a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms of the transaction, which was announced on March 25, were not disclosed. The press release is here.
Founded in 2005, Avista Capital is a leading New York-based private equity firm with over $6 billion invested in more than 35 growth-oriented healthcare businesses globally.
The Ropes & Gray team that represented Avista was led by private equity partner Bob Rivollier and private equity associate David Sandyk (both of New York), and included health care partner Adrianne Ortega (Boston), IP transactions partner Violetta Kokolus (New York), employment, executive compensation & benefits partners Danna Kivell (New York) and Megan Bisk (Boston), tax partner Benjamin Rogers (San Francisco), litigation & enforcement partner Ryan Rohlfsen (Chicago), and real estate partner Peter Alpert (Boston).